Determination of the bioequivalence of a new oral topotecan formulation relative to the current formulation in patients with advanced solid tumors
Type: article
Authors: Oostendorp, R. L., Loftiss, J., Goel, S., Smith, D., Dar, M. M., Witteveen, P. O., Cohen, R. B., Lewis, L. D., Kurian, S., Patnaik, A., Rosing, H., Beijnen, J. H., Voest, E. E., Burris, H., Schellens, J. H. M.
Institutions: Slotervaartziekenhuis, The Netherlands Cancer Institute, Albert Einstein College of Medicine, Yeshiva University, Fox Chase Cancer Center, Dartmouth College, Dartmouth–Hitchcock Medical Center, The University of Texas at San Antonio Health Science Center, Utrecht University, Sarah Cannon Research Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2582411529
